![Drug Information](http://s1.studyres.com/store/data/001173303_1-05a89ffe6fa78c7095270e998a151aae-300x300.png)
Drug Information
... Best taken in the evening to reduce “hang over effect” eg 6-8 pm Usual maintenance dose is 1-=30mg but up to 75mg can be used if benefits outweigh side effects Initial side effects often settle, so encouraging patients to persist can be worthwhile Nortriptyline is less sedating ...
... Best taken in the evening to reduce “hang over effect” eg 6-8 pm Usual maintenance dose is 1-=30mg but up to 75mg can be used if benefits outweigh side effects Initial side effects often settle, so encouraging patients to persist can be worthwhile Nortriptyline is less sedating ...
Projet INCO-DEV / CE 2001
... • approved by FDA for the treatment of community acquired pneumonia, acute bronchitis, acute sinusitis, uncomplicated skin infections, UTIs and gonococcal infections • approved doses range from single 400 mg oral dose to 400 mg (600 mg) oral or intravenous followed by oral doses for 3 to 14 days ...
... • approved by FDA for the treatment of community acquired pneumonia, acute bronchitis, acute sinusitis, uncomplicated skin infections, UTIs and gonococcal infections • approved doses range from single 400 mg oral dose to 400 mg (600 mg) oral or intravenous followed by oral doses for 3 to 14 days ...
Alprazolam Class: Benzodiazepine Indications: Treatment of anxiety
... -Dose reduction: Abrupt discontinuation should be avoided. Daily dose may be decreased by 0.5 mg every 3 days; however, some patients may require a slower reduction. If withdrawal symptoms occur, resume previous dose and discontinue on a less rapid schedule. ...
... -Dose reduction: Abrupt discontinuation should be avoided. Daily dose may be decreased by 0.5 mg every 3 days; however, some patients may require a slower reduction. If withdrawal symptoms occur, resume previous dose and discontinue on a less rapid schedule. ...
B- Efflux pump (T)
... D) Ceftriaxon:3rd generation, not contraindicated in preg., can be used. 18- Which one has high therapeutic index A. Streptomycin B. Cephalosporin {cifazoline} (1st generation and safe) C. Vancomycine D. Doxycycline E. Tetracycline 19- Super infection common with: ...
... D) Ceftriaxon:3rd generation, not contraindicated in preg., can be used. 18- Which one has high therapeutic index A. Streptomycin B. Cephalosporin {cifazoline} (1st generation and safe) C. Vancomycine D. Doxycycline E. Tetracycline 19- Super infection common with: ...
IOPIDINE® 1% IOPIDINE® 0.5% Alcon Apraclonidine HCl Controls
... or type following 2 years of oral administration of apraclonidine to rats at dose levels 20 times the maximum recommended human dose or in mice at dose levels 12 times the maximum recommended human dose. Reproduction and fertility studies in rats showed no adverse effect on male or female fertility ...
... or type following 2 years of oral administration of apraclonidine to rats at dose levels 20 times the maximum recommended human dose or in mice at dose levels 12 times the maximum recommended human dose. Reproduction and fertility studies in rats showed no adverse effect on male or female fertility ...
ampicillin (am-pi-sil-in) - DavisPlus
... CNS: SEIZURES (high doses). GI: PSEUDOMEMBRANOUS COLITIS, diarrhea, nausea, vomiting. Derm: rash, urticaria. Hemat: blood dyscrasias. Misc: allergic reac- ...
... CNS: SEIZURES (high doses). GI: PSEUDOMEMBRANOUS COLITIS, diarrhea, nausea, vomiting. Derm: rash, urticaria. Hemat: blood dyscrasias. Misc: allergic reac- ...
Use in hepatic Impairment: Monoamine oxidase Inhibitors: Children
... commence at 50 mg/day. Therapy for pediatric OCD patients (aged 6-12) should commence at 25mg/day increasing to 50mg/day after 1 week. Subsequent doses may be increased in case of lack ot response in 50mg/day increments up to 200mg/day as needed. However, the generally lower body weights of children ...
... commence at 50 mg/day. Therapy for pediatric OCD patients (aged 6-12) should commence at 25mg/day increasing to 50mg/day after 1 week. Subsequent doses may be increased in case of lack ot response in 50mg/day increments up to 200mg/day as needed. However, the generally lower body weights of children ...
MONTEFIORE HEART FAILURE DISEASE MANAGEMENT
... ACE Inhibitors (ACEI) can alleviate symptoms, improve clinical status, and enhance the overall sense of well-being of patients with heart failure. Because of their favorable effects on survival, ACE inhibitors should be prescribed to ALL patients with heart failure, especially those with LVEF ≤ 40%. ...
... ACE Inhibitors (ACEI) can alleviate symptoms, improve clinical status, and enhance the overall sense of well-being of patients with heart failure. Because of their favorable effects on survival, ACE inhibitors should be prescribed to ALL patients with heart failure, especially those with LVEF ≤ 40%. ...
Asparaginase
... L-Asparaginase can interfere with thyroid function tests. This effect is probably due to a marked reduction in serum concentration of thyroxine-binding globulin, which is observed within 2 days after the first dose. Levels of thyroxine-binding globulin return to normal within 4 weeks of the last dos ...
... L-Asparaginase can interfere with thyroid function tests. This effect is probably due to a marked reduction in serum concentration of thyroxine-binding globulin, which is observed within 2 days after the first dose. Levels of thyroxine-binding globulin return to normal within 4 weeks of the last dos ...
LOGICAL DRUG THERAPY IN CHRONIC KIDNEY DISEASE Dr S
... Because most CKD patients, especially in stage 3 and higher, tend to have cardiac disease, a case can be made for routinely treating such patients with both aspirin and beta-blockers, although this is not widely practiced at all centers. Aspirin has been associated with GI bleeding in end-stage rena ...
... Because most CKD patients, especially in stage 3 and higher, tend to have cardiac disease, a case can be made for routinely treating such patients with both aspirin and beta-blockers, although this is not widely practiced at all centers. Aspirin has been associated with GI bleeding in end-stage rena ...
(Toradol) Fact Sheet
... 1) When administered with other NSAID’s or Aspirin; it may worsen side effects previously listed 2) IM administration of Toradol has been found to reduce the diuretic effects of Lasix 3) Lithium: may increase the effects of lithium ...
... 1) When administered with other NSAID’s or Aspirin; it may worsen side effects previously listed 2) IM administration of Toradol has been found to reduce the diuretic effects of Lasix 3) Lithium: may increase the effects of lithium ...
Pharmacy Information - Vol. II - Issue 2.pub
... Historically, look-alike, sound-alike drug names have resulted in many serious adverse drug events. Miscommunication between physicians, nurses, pharmacists and heath care staff can naturally occur, and the existence of look-alike, sound-alike drug names increases the likelihood of a communication b ...
... Historically, look-alike, sound-alike drug names have resulted in many serious adverse drug events. Miscommunication between physicians, nurses, pharmacists and heath care staff can naturally occur, and the existence of look-alike, sound-alike drug names increases the likelihood of a communication b ...
... Live vaccines should not be given concurrently with ACTEMRA [see Warnings and Precautions]. USE IN SPECIFIC POPULATIONS Pregnancy Teratogenic Effects. Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. ACTEMRA should be used during pregnancy only if the potent ...
Grade 2008-2010 final exam-B
... 4.Drug resistance is the phenomenon that susceptibility of pathogenic microorganisms to drugs becomes lower or even loses after the microorganisms contact with drugs for many times. As a result, the antimicrobial effect of the drugs will decrease or even disappear. 5. Antimicrobial activity:is the a ...
... 4.Drug resistance is the phenomenon that susceptibility of pathogenic microorganisms to drugs becomes lower or even loses after the microorganisms contact with drugs for many times. As a result, the antimicrobial effect of the drugs will decrease or even disappear. 5. Antimicrobial activity:is the a ...
PROPALIN syrup
... Care should be exercised in treating animals with severe renal or hepatic insufficiency diabetes mellitus hyperadrenocorticism glaucoma hyperthyroidism or other metabolic disorders. In bitches less than 1 year old the possibility of anatomical disorders contributing to incontinence should be conside ...
... Care should be exercised in treating animals with severe renal or hepatic insufficiency diabetes mellitus hyperadrenocorticism glaucoma hyperthyroidism or other metabolic disorders. In bitches less than 1 year old the possibility of anatomical disorders contributing to incontinence should be conside ...
IKOREL® - Product Information
... nicorandil and the sympathetic-adrenergic system or neurohumoural mechanism. Indirect activation of the adrenergic system and the renin-angiotensin system may occur as a result of excessive vasodilation or reduction in blood pressure, but only at doses higher than the therapeutic recommended dosage. ...
... nicorandil and the sympathetic-adrenergic system or neurohumoural mechanism. Indirect activation of the adrenergic system and the renin-angiotensin system may occur as a result of excessive vasodilation or reduction in blood pressure, but only at doses higher than the therapeutic recommended dosage. ...
Common Oral Antibiotics for Horses Antibiotics are commonly used
... of the affected area needs to be performed. The culture is sent to a lab where the bacteria are grown and identified. A sensitivity test is then performed to find out which antibiotics will be effective. Some of the more common oral antibiotics in horses include trimethoprim sulfa, metronidazole, en ...
... of the affected area needs to be performed. The culture is sent to a lab where the bacteria are grown and identified. A sensitivity test is then performed to find out which antibiotics will be effective. Some of the more common oral antibiotics in horses include trimethoprim sulfa, metronidazole, en ...
bedaquilin (download, 15.1 KB)
... "[T]he FDA assessment is that the benefits [of bedaquiline] outweigh the risks...for patients with smear-positive, [MDR] pulmonary [TB], for whom there were insufficient treatment options," Dr. Cox and Dr. Laessig write. Moreover, they note that the drug's product label contains a boxed warning abou ...
... "[T]he FDA assessment is that the benefits [of bedaquiline] outweigh the risks...for patients with smear-positive, [MDR] pulmonary [TB], for whom there were insufficient treatment options," Dr. Cox and Dr. Laessig write. Moreover, they note that the drug's product label contains a boxed warning abou ...
8-Anti-mycobacterial drugs
... • Well absorbed and distributed • CNS level variable, 4-60% of serum • Most excreted in urine-- accumulates in renal failure Adverse effects • Dose-dependent optic neuritis, decreased acuity, loss of redgreen differentiation Resistance-- Rapid, use in combination ...
... • Well absorbed and distributed • CNS level variable, 4-60% of serum • Most excreted in urine-- accumulates in renal failure Adverse effects • Dose-dependent optic neuritis, decreased acuity, loss of redgreen differentiation Resistance-- Rapid, use in combination ...
Antimycobacterial drugs
... to the drugs of 1st line. Failure of clinical response There is contraindication for first line drugs. Patient is not tolerating the drugs first line drugs. Resistance ...
... to the drugs of 1st line. Failure of clinical response There is contraindication for first line drugs. Patient is not tolerating the drugs first line drugs. Resistance ...
Dacogen® (Decitabine) for Injection Phase III AML Results Announced
... the need for early institution of growth factors and/or antimicrobial agents for the prevention or treatment of infections in patients with MDS. Dacogen may cause fetal harm when administered to a pregnant woman. Women of childbearing potential should be advised to avoid becoming pregnant while rece ...
... the need for early institution of growth factors and/or antimicrobial agents for the prevention or treatment of infections in patients with MDS. Dacogen may cause fetal harm when administered to a pregnant woman. Women of childbearing potential should be advised to avoid becoming pregnant while rece ...
Use lowest possible doses – monitor for side effects
... • Monitor very carefully for side effects • Monitor for benefit • Consider decreasing the dose if symptoms improve • Monitor for increased sedation and adjust the time of dosing ...
... • Monitor very carefully for side effects • Monitor for benefit • Consider decreasing the dose if symptoms improve • Monitor for increased sedation and adjust the time of dosing ...
Sildenafil - Women and Newborn Health Service
... Flushing, dyspepsia, headache, swelling of the eyelids, dizziness, visual disturbances, raised intra-ocular pressure, nasal congestion, vomiting, rash, serious cardiovascular disorders (including arrhythmia and sudden cardiac death). Sildenafil should not be used in patients receiving nitrates, thos ...
... Flushing, dyspepsia, headache, swelling of the eyelids, dizziness, visual disturbances, raised intra-ocular pressure, nasal congestion, vomiting, rash, serious cardiovascular disorders (including arrhythmia and sudden cardiac death). Sildenafil should not be used in patients receiving nitrates, thos ...
DONNATAL® TABLETS
... necessitate larger doses of the anticoagulant for optimal effect. When the phenobarbital is discontinued, the dose of the anticoagulant may have to be decreased. Phenobarbital may be habit forming and should not be administered to individuals known to be addiction prone or to those with a history of ...
... necessitate larger doses of the anticoagulant for optimal effect. When the phenobarbital is discontinued, the dose of the anticoagulant may have to be decreased. Phenobarbital may be habit forming and should not be administered to individuals known to be addiction prone or to those with a history of ...
Ofloxacin
Ofloxacin is a synthetic antibiotic of the fluoroquinolone drug class considered to be a second-generation fluoroquinolone.Ofloxacin was first patented in 1982 (European Patent Daiichi) and received approval from the U.S. Food and Drug Administration (FDA) on December 28, 1990. Ofloxacin is sold under a wide variety of brand names as well as generic drug equivalents, for oral and intravenous administration. Ofloxacin is also available for topical use, as eye drops and ear drops (marketed as Ocuflox and Floxin Otic respectively in the United States and marketed as Optiflox, eylox respectively in Jordan and Saudi Arabia).Ofloxacin is a racemic mixture, which consists of 50% levofloxacin (the biologically active component) and 50% of its “mirror image” or enantiomer dextrofloxacin.Ofloxacin has been associated with adverse drug reactions, such as tendon damage (including spontaneous tendon ruptures) and peripheral neuropathy (which may be irreversible); tendon damage may manifest long after therapy had been completed, and, in severe cases, may result in lifelong disabilities.